NASDAQ · STOCK
Medtronic plc
$83.79
52W $73.31 – $106.33
68/100
$105.46B
21.8
0.58
Price History (6M)
Executive Summary
6 analysts weighed in with 50% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Weekly trend: uptrend.
- Daily downtrend but weekly uptrend — possible early reversal but not yet confirmed on the daily.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Lower Highs / Lower Lows structure confirms bearish price action.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
68/100
Agreement
60%
Analysts
5
Conviction
Moderate
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 3.5% pays you to wait
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
51
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.20 across 43 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
64.0
Neutral
MACD Histogram
0.315
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$79.94
Resistance
$91.49
Bollinger %B
0.93
Inside Bands
Price vs Moving Averages
EMA 9
$82.19
Above
EMA 21
$81.11
Above
EMA 50
$81.19
Above
EMA 200
$87.23
Below
Fundamental Analysis
Valuation
81
Growth
55
Profitability
67
Financial Health
98
Valuation
P/E Ratio
21.8×
P/B Ratio
2.16×
PEG Ratio
—
Dividend Yield
3.50%
52W High
$106.33
52W Low
$73.31
Quality & Growth
ROE
985.0%
ROA
524.0%
Gross Margin
6531.0%
Operating Margin
1779.0%
Revenue Growth YoY
+843.0%
Debt / Equity
0.57
AI Fundamental Assessment
P/E ratio of 21.8 (inexpensive relative to a 15-40x range); Price-to-book of 2.2x; Revenue growth (YoY) of 8.4%; EPS growth (YoY) of 3.1%; Return on equity of 9.8%; Return on assets of 5.2%; Net margin of 13.2%; Gross margin of 65.3%; Current ratio of 2.13 (healthy short-term liquidity); Debt-to-equity of 0.57; Most recent quarter missed estimates by 0.4%; EPS growth accelerating (+0.0% -> +14.0% QoQ); Analyst estimates rising over recent quarters
Key Risks
- Lower Highs / Lower Lows structure confirms bearish price action.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full MDT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile